Precision surgery for primary liver cancer
- PMID: 31565478
- PMCID: PMC6743624
- DOI: 10.20892/j.issn.2095-3941.2019.0194
Precision surgery for primary liver cancer
Abstract
Liver resection remains the best curative option for primary liver cancer, such as hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma. In particular, in liver resection for HCC, anatomical resection of the tumor-bearing segments is highly recommended to eradicate the intrahepatic metastases spreading through portal venous branches. Anatomical liver resection, including anatomical segmentectomy and subsegmentectomy using the dye-injection method, is technically demanding and requires experience for completion of a precise procedure. The recent development of imaging studies and new computer technologies has allowed for the preoperative design of the operative procedure, intraoperative navigation, and postoperative quality evaluation of the anatomical liver resection. Although these new technologies are related to the progress of artificial intelligence, the actual operative procedure is still performed as human-hand work. A precise anatomical liver resection still requires meticulous exposure of the boundary of hepatic venous tributaries with deep knowledge of liver anatomy and utilization of intraoperative ultrasonography.
Keywords: Preoperative ultrasonic examination; anatomical liver resection; dye injection method; intraoperative ultrasonography; preoperative imaging.
Copyright 2019 Cancer Biology & Medicine.
Figures









Similar articles
-
Benefit of systematic segmentectomy of the hepatocellular carcinoma: revisiting the dye injection method for various portal vein branches.Ann Surg. 2013 Dec;258(6):1014-21. doi: 10.1097/SLA.0b013e318281eda3. Ann Surg. 2013. PMID: 23478518
-
Segmentectomy of the liver.J Hepatobiliary Pancreat Sci. 2012 Jan;19(1):67-71. doi: 10.1007/s00534-011-0448-8. J Hepatobiliary Pancreat Sci. 2012. PMID: 21971690
-
Survival Benefits of Small Anatomical Resection of the Liver for Patients with Hepatocellular Carcinoma and Impaired Liver Function, Based on New-Era Imaging Studies.J Cancer. 2016 May 25;7(9):1029-36. doi: 10.7150/jca.15174. eCollection 2016. J Cancer. 2016. PMID: 27326244 Free PMC article.
-
[Surgical margin status in hepatectomy for liver tumors].Bull Cancer. 2008 Dec;95(12):1183-91. doi: 10.1684/bdc.2008.0758. Bull Cancer. 2008. PMID: 19091652 Review. French.
-
Progress of liver resection for hepatocellular carcinoma in Taiwan.Jpn J Clin Oncol. 2017 May 1;47(5):375-380. doi: 10.1093/jjco/hyx007. Jpn J Clin Oncol. 2017. PMID: 28159964 Review.
Cited by
-
Advances in magnetic resonance imaging for the evaluation of colorectal liver metastases in context of individualized precision medicine.ILIVER. 2025 May 12;4(2):100168. doi: 10.1016/j.iliver.2025.100168. eCollection 2025 Jun. ILIVER. 2025. PMID: 40636465 Free PMC article. Review.
-
Design of Path-Planning System for Interventional Thermal Ablation of Liver Tumors Based on CT Images.Sensors (Basel). 2024 May 30;24(11):3537. doi: 10.3390/s24113537. Sensors (Basel). 2024. PMID: 38894328 Free PMC article.
-
Novel techniques of liver segmental and subsegmental pedicle anatomy from segment 1 to segment 8.World J Gastrointest Surg. 2024 Dec 27;16(12):3806-3817. doi: 10.4240/wjgs.v16.i12.3806. World J Gastrointest Surg. 2024. PMID: 39734440 Free PMC article.
-
Anatomical Resection Improved the Outcome of Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis of a Retrospective Cohort.J Oncol. 2022 Oct 25;2022:4446243. doi: 10.1155/2022/4446243. eCollection 2022. J Oncol. 2022. PMID: 36330355 Free PMC article.
-
Laparoscopic left hemihepatectomy guided by real-time indocyanine green fluorescence imaging using the arantius-first approach.World J Surg Oncol. 2023 Sep 6;21(1):282. doi: 10.1186/s12957-023-03165-9. World J Surg Oncol. 2023. PMID: 37674215 Free PMC article.
References
-
- Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3:1683–91. doi: 10.1001/jamaoncol.2017.3055. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources